{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T23:28:25Z","timestamp":1769124505930,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ijcard.2016.06.190","type":"journal-article","created":{"date-parts":[[2016,6,25]],"date-time":"2016-06-25T16:50:15Z","timestamp":1466873415000},"page":"56-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Association between long-term prescription of aldosterone antagonist and the progression of heart failure with preserved ejection fraction in hypertensive patients"],"prefix":"10.1016","volume":"220","author":[{"given":"Jun","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-qi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-hua","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuo-jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-fang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-shui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.06.190_bb0005","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.190_bb0010","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/HCO.0000000000000163","article-title":"Advances in the pathophysiology and treatment of heart failure with preserved ejection fraction","volume":"30","author":"Tannenbaum","year":"2015","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.190_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jhh.2014.36","article-title":"Myocardial remodeling in hypertension","volume":"2","author":"Nadruz","year":"2015","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.ijcard.2016.06.190_bb0020","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jacc.2006.08.050","article-title":"Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling\/dysfunction","volume":"49","author":"Melenovsky","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.190_bb0025","doi-asserted-by":"crossref","DOI":"10.1177\/2047487316636260","article-title":"Long-term prescription of beta-blocker delays the progression of heart failure with preserved ejection fraction in patients with hypertension: a retrospective observational cohort study","author":"Gu","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ijcard.2016.06.190_bb0030","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1388-9842(99)00039-2","article-title":"Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigators","volume":"1","author":"Cleland","year":"1999","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.06.190_bb0035","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.06.190_bb0040","doi-asserted-by":"crossref","unstructured":"Yamamoto K, Origasa H, Hori M, J-DHF investigators. Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF). Eur. J. Heart Fail. 2013;15:110\u2013118.","DOI":"10.1093\/eurjhf\/hfs141"},{"key":"10.1016\/j.ijcard.2016.06.190_bb0045","first-page":"809","article-title":"Effects of low-dose spironolactone combined with irbesartan on cardiac hypertrophy induced by pressure overload in rats","volume":"6","author":"Ma","year":"2014","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.ijcard.2016.06.190_bb0050","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.06.190_bb0055","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.2013.905","article-title":"Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the ALDO-DHF randomized controlled trial","volume":"309","author":"Edelmann","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2016.06.190_bb0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/jhh.2014.83","article-title":"Effect of spironolactone on diastolic function in hypertensive left ventricular hypertrophy","volume":"29","author":"Gupta","year":"2015","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.ijcard.2016.06.190_bb0065","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/ajh.2007.47","article-title":"Effects of dual blockade of renin\u2013angiotensin system on concentric left ventricular hypertrophy in essential hypertension: a randomized,controlled pilot study","volume":"21","author":"Grandi","year":"2008","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ijcard.2016.06.190_bb0070","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/echo.12548","article-title":"Impact of azelnidipine and amlodipine on left ventricular mass and longitudinal function in hypertensive patients with left ventricular hypertrophy","volume":"31","author":"Motoki","year":"2014","journal-title":"Echocardiography"},{"key":"10.1016\/j.ijcard.2016.06.190_bb0075","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/hr.2010.237","article-title":"The effect of losartan and amlodipine on left ventricular diastolic function and atherosclerosis in Japanese patients with mild-to-moderate hypertension (J-ELAN) study","volume":"3","author":"Yamamoto","year":"2011","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ijcard.2016.06.190_bb0080","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCULATIONAHA.108.845792","article-title":"The progression of hypertensive heart disease","volume":"123","author":"Drazner","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.06.190_bb0085","doi-asserted-by":"crossref","first-page":"e466","DOI":"10.1161\/CIRCULATIONAHA.111.067918","article-title":"Aldosterone, mineralocorticoid receptor activation, and cardiovascular remodeling","volume":"124","author":"Leopold","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.06.190_bb0090","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S1734-1140(11)70613-2","article-title":"Long-term use of low-dose spironolactone in spontaneously hypertensive rats: effects on left ventricular hypertrophy and stiffness","volume":"63","author":"Baldo","year":"2011","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ijcard.2016.06.190_bb0095","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/HYPERTENSIONAHA.115.06054","article-title":"Rac1-mediated activation of mineralocorticoid receptor in pressure overload-induced cardiac injury","volume":"67","author":"Ayuzawa","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2016.06.190_bb0100","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/HYPERTENSIONAHA.111.190512","article-title":"Aldosterone inhibits antifibrotic factors in mouse hypertensive heart","volume":"59","author":"Azibani","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2016.06.190_bb0105","doi-asserted-by":"crossref","first-page":"H1484","DOI":"10.1152\/ajpheart.01000.2010","article-title":"Mineralocorticoid receptor blockade improves diastolic function independent of blood pressure reduction in a transgenic model of RAAS overexpression","volume":"300","author":"Habibi","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ijcard.2016.06.190_bb0110","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.169961","article-title":"Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial","volume":"57","author":"V\u00e1clav\u00edk","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2016.06.190_bb0115","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000162","article-title":"Effect of spironolactone in resistant arterial hypertension: a randomized, double-blind, placebo-controlled trial (ASPIRANT-EXT)","volume":"93","author":"V\u00e1clav\u00edk","year":"2014","journal-title":"Medicine (Baltimore)"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316311615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316311615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:50:58Z","timestamp":1536627058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316311615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":23,"alternative-id":["S0167527316311615"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.190","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between long-term prescription of aldosterone antagonist and the progression of heart failure with preserved ejection fraction in hypertensive patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}